Dow Down 0.25% Nasdaq Down 0.14%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
7.58 Down 0.01(0.13%) Sep 29, 4:00PM EDT
|After Hours : 7.50 Down 0.08 (1.06%) Sep 29, 7:59PM EDT
Prev Close:7.59
Open:7.54
Bid:7.01 x 100
Ask:7.96 x 100
1y Target Est:7.67
Beta:0.51
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:7.51 - 7.66
52wk Range:7.38 - 10.26
Volume:2,126,646
Avg Vol (3m):2,910,430
Market Cap:1.22B
P/E (ttm):4.58
EPS (ttm):1.65
Div & Yield:0.60 (6.60%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLIDown 0.13%1.22B
AMGNDown 0.70%106.40B
SGENDown 7.20%4.74B
XOMADown 1.39%457.22M

Key Statistics

Forward P/E (1 yr):3.13
P/S (ttm):2.78
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :2.20
Quarterly EPS Est (Sep-14) :0.61
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback